Analgesic effects of intra-nasal enkephalins

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 9, 2003, Pages 1207-1212

  Gwak, H S ^a   Cho, Y M ^b   Chun, I K ^b  

^a Chosun University   (South Korea)

^b Dongduk Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; AZELAIC ACID; EDETIC ACID; ENKEPHALIN; ENZYME INHIBITOR; KETOPROFEN; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALINAMIDE[2 DEXTRO ALANINE]; LEVO ALPHA LYSOPHOSPHATIDYLCHOLINE; MORPHINE; PENETRATION ENHANCING AGENT; POVIDONE; THIOMERSAL; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG POTENCY; DRUG POTENTIATION; INHIBITION KINETICS; MOUSE; NONHUMAN; STATISTICAL ANALYSIS; TIME; WRITHING TEST;

ACETIC ACID; ADMINISTRATION, INTRANASAL; ANALGESICS; ANIMALS; DICARBOXYLIC ACIDS; DRUG SYNERGISM; EDETIC ACID; ENKEPHALIN, LEUCINE; ENZYME INHIBITORS; KETOPROFEN; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED ICR; PAIN; PAIN MEASUREMENT; SURFACE-ACTIVE AGENTS; THIMEROSAL;

EID: 0141571139     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021774     Document Type: Article

References (33)

1. Amanuma, F., Wakaumi, C., Tanaka, M., Muramatsu, M., Aihara, H. (1984) The analgesic effects of non-steroidal anti-inflammatory drugs on acetylcholine-induced writhing in mice. Folia Pharmacol. Jpn 84: 543-551
2. Barclay, R., Phillips, M. (1980) Inhibition of enkephalin-degrading aminopeptidase activity by certain peptides. Res. Commun. 96: 1732-1738
3. Belluzzi, J. D., Grant, N., Garsky, V., Sarantakis, D., Wise, C. D., Stein, L. (1976) Analgesia induced in vivo by central administration of enkephalin in rat. Nature 260: 625-626
4. Choi, H. K., Flynn, G. L., Amidon, G. L. (1990) Transdermal delivery of bioactive peptides: The effect of n-decylmethyl sulfoxide, pH and inhibitors on enkephalin metabolism and transport. Pharm. Res. 7: 1099-1106
5. Chun, I. K., Chien, Y. W. (1993) Transmucosal delivery of methionine enkephalin. I: Solution stability and kinetics of degradation in various rabbit mucosa extracts. J. Pharm. Sci. 82: 373-378
6. Chun, I. K., Chien, Y. W. (199) Stabilization of methionine enkephalin in various rabbit mucosal extracts by enzyme inhibitors. Int. J. Pharm. 121: 217-231
7. 2]-leucine enkephalinamide in various rabbit mucosa extracts. Yakhak Hoeji 38: 530-543
8. Chun, I. K., Kim, D. D., Wang, Y. J., Chien, Y. W. (1996a) Permeation enhancement of methionine enkephalin by combinations of enzyme inhibitors and enhancers. STP Pharma Sci. 6: 148-156
9. 2]-leucine enkephalinamide in various rabbit mucosal extracts by inhibitors. J. Kor. Pharm. Sci. 26: 175-185
10. Corbo, D. C., Liu, J. C., Chien, Y. W. (1990) Characterization of the barrier properties of mucosal membranes. J. Pharm. Sci. 79: 202-206
11. Dzoljic, D., Dzoljic, M. R. (1989) Modification of morphine withdrawal in rats by alterations of the endogenous opioid system: Effects of actinonin and GEMSA. Drug. Dev. Res. 18: 255-261
12. Faraj, J. A., Hussain, A. A., Aramaki, Y., Iseki, K., Kagoshima, M., Dittert, L. W. (1990a) Mechanism of nasal absorption of drugs. III. Nasal absorption of leucine enkephalin. J. Pharm. Sci. 79: 698-702
13. Faraj, J. A., Hussain, A. A., Aramaki Y., Iseki, K., Kagoshima, M., Dittert, L. W. (1990b) Mechanism of nasal absorption of drugs. IV. Plasma levels of radioactivity following intranasal administration of [3H]-leucine enkephalin. J. Pharm. Sci. 79: 768-770
14. Farraj, N. F., Johansen, B. R., Davis, S. S., Illum, L. (1990) Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Control. Release 13: 253-261
15. Fisher, A. N., Farraj, N. F., O'Hagan, D. T., Jabbal-Gill, I., Johansen, B. R., Davis, S. S., ILlum, L. (1991) Effect of L-α-lysophosphatidylcholine on the nasal absorption of human growth hormone in three animal species. Int. J. Pharm. 74: 147-156
16. Frederickson, R. C., Geary, L. E. (1982) Endogenous opioid peptides: Review of physiological, pharmacological and clinical aspects. Prog. Neurobiol. 19: 19-69
17. 2]-leucine enkephalinamide across nasal, rectal and vaginal mucosae of rabbit. J. Appl. Pharmacol. 10: 104-113
18. Hussain, M. A., Shenvi, A. B., Rowe, S. M., Shefter, E. (1989) The use of α-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption. Pharm. Res. 74: 394-398
19. Hussain, M. A., Seetharam, R., Wilk, R. R., Aungst, B. J., Kettner, C. A. (1995) Nasal mucosal metabolism and absorption of pentapeptide enkephalin analogs having varying N-terminal amino acids. J. Pharm. Sci. 84: 62-64
20. Illum, L., Farraj, N. F., Critchley, H., Davis, S. S. (1988) Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 46: 261-265
21. Illum, L., Farraj, N. F., Critchley, H., Johansen, B. R., Davis, S. S. (1989) Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine. Int. J. Pharm. 57: 49-54
22. Jankovic, B. D., Maric, D. (1988) Enkephalins modulate in vivo immune reactions through delta- and mu-opioid receptors. Ann. N. Y. Acad. Sci. 540: 691-693
23. Kerchner, G. A., Geary, L. E., (1983) Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa. J. Pharm. Exp. Ther. 226: 33-38
24. Malfroy, B., Swerts, J. P., Guyon, A., Roques, B. P., Schwarts, J. C. (1978) High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 276: 523-526
25. O'Hagan, D. T., Critchley, H., Farraj, N. F., Fisher, A. N., Johansen, B. R., Davis, S. S., Illum, L. (1990) Nasal absorption enhancers for biosynthetic human growth hormone in rats. Pharm. Res. 7: 772-776
26. Passi, S., Picardo, M., Mingrone, G., Brethnach, A. S., Nazzaro-Porro, M. (1989) Azelaic acid-biochemistry and metabolism. Acta. Derm. Venereol. Suppl. 143: 8-13
27. Saito, H., Nomura, Y. (1989) Screening methods for drug evaluation. Pharm. Res. Dev. 9: 102-122
28. Sakane, T., Akizuki, M., Yamashita, S., Sezaki, H., Nadai, T. (1994) Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: The relation to the dissociation of the drug. J. Pharm. Pharmacol. 46: 378-379
29. Sayani, A. P., Chun, I. K., Chien, Y. W. (1993) Transmucosal delivery of leucine enkephalin: Stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae. J. Pharm. Sci. 82: 1179-1185
30. Sayani, A. P., Kim, D. D., Frenkl, T. L., Chun, I. K., Wang, Y. J., Chien, Y. W. (1994) Transmucosal delivery of enkephalins: Comparative enhancing effects of dihydrofusidates and bile salts. STP Pharma Sci. 4: 470-476
31. Schwartz, J. C., Malfroy, B., De La Baume, S. (1981) Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ("enkephalinase") as neuropeptidase. Life Sci. 29: 1715-1740
32. Stratford R. E. Jr., Carson, L. W., Dodda-Kashi, S., Lee, V. H. L. (1988) Systemic absorption of oculary administered enkephalinamide and inulin in the albino rabbit: Extent, pathway, and vehicle effects. J. Pharm. Sci. 77: 838-842
33. Su, K. S. E., Campanale, K. M., Mendelsohn, L. G., Kerchner, G. A., Gries, C. L. (1985) Nasal delivery of polypeptides I: Nasal absorption of enkephalins in rats. J. Pharm. Sci. 74: 394-398